Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
$40
1-199 Others
$30
200-499 Others
$20
≥500 Others
Product Description
Paclitaxel 98% is a high-purity pharmaceutical active pharmaceutical ingredient (API) widely used in oncology drug development and sterile injectable chemotherapy formulations. It is a naturally derived diterpenoid compound originally extracted from Taxus species and remains one of the most important anticancer agents in modern pharmaceutical manufacturing.
In global pharmaceutical supply chains, Paclitaxel plays a key role in GMP-certified production, Supplement Contract Manufacturing, and CDMO operations. It is widely applied in injectable drug formulation, oncology R&D, and clinical trial material supply.
Content Note: Prepared by our technical team based on peer-reviewed scientific literature. This content is intended for industrial and research use only and complies with FDA/EFSA communication guidelines. Last reviewed: June 2026
According to a study in Journal of Clinical Oncology (1998), paclitaxel demonstrated significant therapeutic efficacy in patients with ovarian and breast cancer as part of combination chemotherapy regimens.
According to a study in The New England Journal of Medicine (1994), paclitaxel showed clinically meaningful anti-tumor activity in previously treated ovarian cancer patients, establishing its importance in chemotherapy protocols.
Paclitaxel 98% is manufactured under strict GMP-controlled environments to ensure high purity, stability, and pharmaceutical-grade compliance for global distribution.
| Parameter | Specification |
|---|---|
| Active Ingredient | Paclitaxel |
| Purity | ≥ 98% |
| Appearance | White to off-white crystalline powder |
| Test Method | HPLC |
| Form | API powder / injectable intermediate |
| Storage Condition | 2–8°C, protected from light and moisture |
The quality of Paclitaxel 98% depends on extraction source, purification technology, and GMP-certified manufacturing systems. Advanced processing ensures high bioactivity and low impurity levels.
| Process Stage | Quality Impact |
|---|---|
| Natural extraction from Taxus species | Maintains molecular integrity and therapeutic activity |
| Advanced chromatographic purification | Reduces impurities and improves safety profile |
| Sterile crystallization process | Enhances stability for injectable applications |
| API | Mechanism | Clinical Application |
|---|---|---|
| Paclitaxel | Microtubule stabilization | Breast, ovarian, lung cancers |
| Docetaxel | Microtubule stabilization | Solid tumor chemotherapy |
| Doxorubicin | DNA intercalation | Broad-spectrum oncology treatment |
Paclitaxel 98% is widely used in pharmaceutical oncology manufacturing and clinical drug development programs.
It is also applied in research involving Plant Extracts , Standardized Extracts, Herbal Extracts , Nutritional Ingredients, and Antioxidants for pharmaceutical innovation and formulation science.
We supply Paclitaxel 98% under strict GMP-certified systems with full regulatory support for global pharmaceutical markets.
It is used as an active pharmaceutical ingredient in chemotherapy drug production for cancer treatment.
Yes, it is commonly processed into sterile injectable dosage forms under GMP conditions.
The standard purity is ≥98%, confirmed by HPLC testing methods.
It should be stored at 2–8°C in a sealed, light-protected environment.
Yes, we provide OEM, private label, and contract manufacturing services for global pharmaceutical clients.

Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it